SEC Form D private-offering filing
Amlogenyx Inc.
A new SEC Form D private-offering notice from Novato, CA, a $20,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Clinical-stage biotech developing AAV gene therapies to reduce amyloid accumulation in Alzheimer's disease
Filed 2026-07-09Filed to raise $20,000,000First money in 2026-07-01Raised so far $10,000,000HQ (as filed) Novato, CASector Biotech ✓Stage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Website verified amlogenyx.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.